@xconomy.com 3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@venturebeat.com 4 years ago
Harvard Medical School’s AI can detect genetic defect that causes some cancers
@engadget.com 5 years ago
23andMe, Ancestry and others agree to genetic privacy guidelines
@techcrunch.com 7 years ago
Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis